Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ariel Berlinski

TitleProfessor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPeds Pediatrics, College of Medicine
DivisionPeds Pulmonary
Address ACH Administration
1900 Maryland Street
Mail Slot # 512-17
Little Rock AR 72202
Phone501-364-1006
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    002928Y121     (BERLINSKI, ARIEL)Apr 1, 2023 - Jun 30, 2024
    Cystic Fibrosis Foundation
    Cystic Fibrosis Foundation Therapeutics Developmen-Renewal
    Role: Principal Investigator
    GR039169     (BERLINSKI, ARIEL)Mar 1, 2023 - Feb 29, 2024
    UAMS ACHRI Flow Through
    GR036169 Berlinski ACRI OUTREACH Study
    Role: Principal Investigator
    GR039172     (BERLINSKI, ARIEL)Jul 1, 2022 - Jun 30, 2023
    UAMS ACHRI Flow Through
    GR039172 Berlinski CFF Database
    Role: Principal Investigator
    JOHNSO22Y0     (BERLINSKI, ARIEL)Apr 1, 2022 - Mar 31, 2023
    Cystic Fibrosis Foundation
    Cystic Fibrosis Foundation Therapeutics Development Center
    Role: Principal Investigator
    ANDERS14YO     (JOHNSON, LARRY G)Jan 1, 2017 - Mar 31, 2021
    Cystic Fibrosis Foundation
    CFT Therapeutic Development Center Renewal 2018 - Continuation - Continuation
    Role: Co-Investigator
    ANDERS14Y0     (JOHNSON, LARRY)Jan 1, 2017 - Mar 31, 2020
    Cystic Fibrosis Foundation
    CFT Therapeutic Development Center Renewal 2018 - Continuation - Continuation
    Role: Co-Principal Investigator
    039076     (BERLINSKI, ARIEL)Jul 1, 2016 - Jun 30, 2021
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator
    ACRI # 039034     (BERLINSKI, ARIEL)Jul 1, 2016 - Jun 30, 2021
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator
    ACRI # 039035     (BERLINSKI, ARIEL)Jul 1, 2016 - Jun 30, 2021
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator
    ACRI # 039036     (BERLINSKI, ARIEL)Jul 1, 2016 - Jun 30, 2021
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator
    ACRI#039034     (BERLINSKI, ARIEL)Jul 1, 2016 - Jun 30, 2021
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator
    ACRI#039035     (BERLINSKI, ARIEL)Jul 1, 2016 - Jun 30, 2021
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator
    ACRI#039036     (BERLINSKI, ARIEL)Jul 1, 2016 - Jun 30, 2021
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator
    CFF#ANDERS14Y0     (JOHNSON, LARRY G)Jan 1, 2015 - Dec 31, 2015
    Cystic Fibrosis Foundation
    CFFT Therapeutics Dev Center Renewal 2014
    Role: Co-Investigator
    C005AD-TDC11Y     (ANDERSON, PAULA)Jan 1, 2009 - Dec 31, 2013
    Cystic Fibrosis Foundation
    Therapeutic Development Center
    Role: Co-Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Agoramurthi K, Berlinski A. Effect of Disinfection Method and Testing Methodology on the Performance of a Breath-Enhanced Jet Nebulizer. Pharmaceutics. 2023 Dec 21; 16(1). PMID: 38276494.
      View in: PubMed
    2. Berlinski A, Willis LD. Albuterol Delivery During Invasive Mechanical Ventilation via In-Line Intrapulmonary Percussive Ventilation in a Pediatric Lung Model. Respir Care. 2023 Oct 03. PMID: 37788859.
      View in: PubMed
    3. Berlinski A. Innovation in Drug Delivery Through High-Flow Nasal Cannula Systems and Its Evaluation. Respir Care. 2023 09; 68(9):1325-1326. PMID: 37648444.
      View in: PubMed
    4. Li J, Liu K, Lyu S, Jing G, Dai B, Dhand R, Lin HL, Pelosi P, Berlinski A, Rello J, Torres A, Luyt CE, Michotte JB, Lu Q, Reychler G, Vecellio L, de Andrade AD, Rouby JJ, Fink JB, Ehrmann S. Aerosol therapy in adult critically ill patients: a consensus statement regarding aerosol?administration strategies?during various modes of respiratory support. Ann Intensive Care. 2023 Jul 12; 13(1):63. PMID: 37436585.
      View in: PubMed
    5. Jones TD, Willis LD, Spray BJ, Berlinski A. Curriculum and Competency Evaluation in Respiratory Therapy Entry-to-Practice Programs. Respir Care. 2023 10; 68(10):1356-1364. PMID: 37311629.
      View in: PubMed
    6. Long HM, Cobb KA, Leisenring PA, King SE, Willis LD, Pesek RD, Berlinski A. Implementation of a Respiratory Therapist-Driven Protocol for Spirometry and Asthma Education in a Pediatric Out-Patient Primary Care Setting. Respir Care. 2023 09; 68(9):1195-1201. PMID: 37193600.
      View in: PubMed
    7. Berlinski A, Leisenring P, Willis L, King S. Home Spirometry in Children with Cystic Fibrosis. Bioengineering (Basel). 2023 Feb 11; 10(2). PMID: 36829736.
      View in: PubMed
    8. Awad S, Berlinski A. Accidental Decannulation in Tracheostomized Children. Respir Care. 2023 02; 68(2):284-285. PMID: 37615522.
      View in: PubMed
    9. Mayer-Hamblett N, Ratjen F, Russell R, Donaldson SH, Riekert KA, Sawicki GS, Odem-Davis K, Young JK, Rosenbluth D, Taylor-Cousar JL, Goss CH, Retsch-Bogart G, Clancy JP, Genatossio A, O'Sullivan BP, Berlinski A, Millard SL, Omlor G, Wyatt CA, Moffett K, Nichols DP, Gifford AH. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials. Lancet Respir Med. 2023 04; 11(4):329-340. PMID: 36343646.
      View in: PubMed
    10. Berlinski A, Spiva J. In Vitro Characterization of Aerosolized Albuterol Generated by a Jet Nebulizer and Delivered through a Heated Flow Nasal Cannula System. Pharmaceuticals (Basel). 2022 Oct 18; 15(10). PMID: 36297393.
      View in: PubMed
    11. Willis LD, Danner NP, Lloyd TL, Carper NL, Berlinski A. Safe and Effective Use of Score-Based Continuous Albuterol Therapy in a Pathway for Treatment of Pediatric Asthma Exacerbation. Respir Care. 2022 11; 67(11):1396-1404. PMID: 35944965.
      View in: PubMed
    12. Berlinski A. Changing Positions When New Data Are Available Is Essential to Science: A Tale of a Breath-Enhanced Nebulizer. Respir Care. 2022 08; 67(8):1064-1065. PMID: 35882446.
      View in: PubMed
    13. Kannan R, Arey R, Przekwas A, Berlinski A, Singh N. Evaluating Drug Deposition Patterns from Turbuhaler? in Healthy and Diseased Lung Models of Preschool Children. J Pulm Med Respir Care. 2022; 4(1). PMID: 35224564.
      View in: PubMed
    14. Lester M, Eidson D, Blair S, Gray S, Sapp P, Zupancic FJ, Marshall BC, Berlinski A. Cystic Fibrosis Foundation Nebulizer and Compressor Accessibility Survey. Respir Care. 2021 Dec; 66(12):1840-1847. PMID: 34610985.
      View in: PubMed
    15. Ararat E, Sonawalla A, Berlinski A, Tas E. Nutritional status between 5-10 years is associated with cystic fibrosis-related diabetes in adolescence. Pediatr Pulmonol. 2021 10; 56(10):3217-3222. PMID: 34245493.
      View in: PubMed
    16. Qaqish R, Berlinski A. Effects of Shake-Actuation Delay on Delivered Dose and Aerosol Characteristics of an Albuterol Suspension From a Pressurized Metered-Dose Inhaler. Respir Care. 2021 Aug; 66(8):1315-1322. PMID: 34103384.
      View in: PubMed
    17. Berlinski A. In Vitro Comparison of Different Nebulizers Delivering 7% Hypertonic Saline. Respir Care. 2021 Oct; 66(10):1582-1587. PMID: 33947793.
      View in: PubMed
    18. Napolitano N, Berlinski A, Walsh BK, Ginier E, Strickland SL. AARC Clinical Practice Guideline: Management of Pediatric Patients With Oxygen in the Acute Care Setting. Respir Care. 2021 Jul; 66(7):1214-1223. PMID: 33790048.
      View in: PubMed
    19. Berlinski A. Innovation in Aerosol Drug Delivery During Adult Mechanical Ventilation. Respir Care. 2020 10; 65(10):1624-1625. PMID: 32973105.
      View in: PubMed
    20. Berlinski A. Implementation of pediatric home spirometry: potential height bias. J Cyst Fibros. 2021 07; 20(4):719-720. PMID: 32873523.
      View in: PubMed
    21. Mitchell JP, Berlinski A, Canisius S, Cipolla D, Dolovich MB, Gonda I, Hochhaus G, Kadrichu N, Lyapustina S, Mansour HM, Darquenne C, Clark AR, Newhouse M, Ehrmann S, Humphries R, Boushey H. Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking Group. J Aerosol Med Pulm Drug Deliv. 2020 08; 33(4):235-238. PMID: 32589076.
      View in: PubMed
    22. Berlinski A. 2019 Year in Review: Aerosol Therapy. Respir Care. 2020 May; 65(5):705-712. PMID: 32345761.
      View in: PubMed
    23. Com G, Agarwal A, Bai S, Hu Z, Goode G, McCarty H, Berlinski A. Outcomes and Safety of Outpatient Parenteral Antimicrobial Therapy in Select Children with Cystic Fibrosis. Pediatr Allergy Immunol Pulmonol. 2019 Dec 01; 32(4):149-154. PMID: 32140285.
      View in: PubMed
    24. Berlinski A, Velasco J. Albuterol Delivery Efficiency in a Pediatric Model of Noninvasive Ventilation With a Single-Limb Circuit. Respir Care. 2019 Nov; 64(11):1366-1370. PMID: 31113855.
      View in: PubMed
    25. Berlinski A. Be Aware of Intrapulmonary Percussive Ventilation. Respir Care. 2019 05; 64(5):612-613. PMID: 31023882.
      View in: PubMed
    26. Berlinski A, Chervinskiy SK, Simmons AL, Leisenring P, Harwell SA, Lawrence DJ, Jones SM, Carroll JL, Perry TT. Delivery of high-quality pediatric spirometry in rural communities: A novel use for telemedicine. J Allergy Clin Immunol Pract. 2018 May - Jun; 6(3):1042-1044. PMID: 29428244.
      View in: PubMed
    27. Awad SM, Berlinski A. Crossover Evaluation of Compressors and Nebulizers Typically Used by Cystic Fibrosis Patients. Respir Care. 2018 Mar; 63(3):294-300. PMID: 29432139.
      View in: PubMed
    28. Berlinski A, von Hollen D, Pritchard JN, Hatley RH. Delay Between Shaking and Actuation of a Hydrofluoroalkane Fluticasone Pressurized Metered-Dose Inhaler. Respir Care. 2018 Mar; 63(3):289-293. PMID: 29162718.
      View in: PubMed
    29. Velasco J, Berlinski A. Albuterol Delivery Efficiency in a Pediatric Model of Noninvasive Ventilation With Double-Limb Circuit. Respir Care. 2018 Feb; 63(2):141-146. PMID: 29114011.
      View in: PubMed
    30. Berlinski A, Pennington D. Effect of Interval Between Actuations of Albuterol Hydrofluoroalkane Pressurized Metered-Dose Inhalers on Their Aerosol Characteristics. Respir Care. 2017 Sep; 62(9):1123-1130. PMID: 28611228.
      View in: PubMed
    31. Berlinski A. Pediatric Aerosol Therapy. Respir Care. 2017 Jun; 62(6):662-677. PMID: 28546371.
      View in: PubMed
    32. Perry TT, Marshall A, Berlinski A, Rettiganti M, Brown RH, Randle SM, Luo C, Bian J. Smartphone-based vs paper-based asthma action plans for adolescents. Ann Allergy Asthma Immunol. 2017 03; 118(3):298-303. PMID: 28111110.
      View in: PubMed
    33. Berlinski A, Ari A, Davies P, Fink J, Majaesic C, Reychler G, Tatla T, Amirav I. Workshop Report: Aerosol Delivery to Spontaneously Breathing Tracheostomized Patients. J Aerosol Med Pulm Drug Deliv. 2017 Aug; 30(4):207-222. PMID: 28075193.
      View in: PubMed
    34. Berlinski A, von Hollen D, Hatley RHM, Hardaker LEA, Nikander K. Drug Delivery in Asthmatic Children Following Coordinated and Uncoordinated Inhalation Maneuvers: A Randomized Crossover Trial. J Aerosol Med Pulm Drug Deliv. 2017 Jun; 30(3):182-189. PMID: 27977309.
      View in: PubMed
    35. Cockerham JR, Lowe GR, Willis R, Stecks RM, Berlinski A. Quality Improvement Project to Improve Timeliness Between Bronchodilator Treatments from Emergency Department to Medical Wards. Respir Care. 2016 Dec; 61(12):1573-1579. PMID: 27827333.
      View in: PubMed
    36. Berlinski A, Cooper B. Oronasal and Tracheostomy Delivery of Soft Mist and Pressurized Metered-Dose Inhalers With Valved Holding Chamber. Respir Care. 2016 Jul; 61(7):913-9. PMID: 27006348.
      View in: PubMed
    37. Berlinski A. Transnasal Aerosol Delivery to Pediatric Patients: Jet Versus Vibrating Mesh--Reply. Respir Care. 2015 Oct; 60(10):e168-9. PMID: 26405191.
      View in: PubMed
    38. Cooper B, Berlinski A. Albuterol Delivery via Facial and Tracheostomy Route in a Model of a Spontaneously Breathing Child. Respir Care. 2015 Dec; 60(12):1749-58. PMID: 26286736.
      View in: PubMed
    39. Willis LD, Berlinski A. Mechanical Insufflation-Exsufflation: The Good, the Bad, and the Ugly. Respir Care. 2015 Jul; 60(7):1081-2. PMID: 26113568.
      View in: PubMed
    40. Berlinski A. Assessing New Technologies in Aerosol Medicine: Strengths and Limitations. Respir Care. 2015 Jun; 60(6):833-47; discussion 847-9. PMID: 26070578.
      View in: PubMed
    41. Berlinski A, Willis JR. Effect of Tidal Volume and Nebulizer Type and Position on Albuterol Delivery in a Pediatric Model of Mechanical Ventilation. Respir Care. 2015 Oct; 60(10):1424-30. PMID: 25969513.
      View in: PubMed
    42. Agarwal A, Willis D, Tang X, Bauer M, Berlinski A, Com G, Ward WL, Carroll JL. Transition of respiratory technology dependent patients from pediatric to adult pulmonology care. Pediatr Pulmonol. 2015 Dec; 50(12):1294-300. PMID: 25652000.
      View in: PubMed
    43. El Taoum KK, Xi J, Kim J, Berlinski A. In Vitro Evaluation of Aerosols Delivered via the Nasal Route. Respir Care. 2015 Jul; 60(7):1015-25. PMID: 25587167.
      View in: PubMed
    44. Berlinski A. Effect of mask dead space and occlusion of mask holes on delivery of nebulized albuterol. Respir Care. 2014 Aug; 59(8):1228-32. PMID: 24327744.
      View in: PubMed
    45. Berlinski A. The order of the factors affects a product! Respir Care. 2014 Mar; 59(3):441-2. PMID: 24587481.
      View in: PubMed
    46. Com G, Carroll JL, Castro MM, Tang X, Jambhekar S, Berlinski A. Predictors and outcome of low initial forced expiratory volume in 1 second measurement in children with cystic fibrosis. J Pediatr. 2014 Apr; 164(4):832-8. PMID: 24418473.
      View in: PubMed
    47. Awad S, Williams DK, Berlinski A. Longitudinal evaluation of compressor/nebulizer performance. Respir Care. 2014 Jul; 59(7):1053-61. PMID: 24149670.
      View in: PubMed
    48. Berlinski A. In vitro evaluation of positive expiratory pressure devices attached to nebulizers. Respir Care. 2014 Feb; 59(2):216-22. PMID: 23920213.
      View in: PubMed
    49. Xi J, Si X, Zhou Y, Kim J, Berlinski A. Growth of nasal and laryngeal airways in children: implications in breathing and inhaled aerosol dynamics. Respir Care. 2014 Feb; 59(2):263-73. PMID: 23821760.
      View in: PubMed
    50. Berlinski A, Willis JR. Albuterol delivery by 4 different nebulizers placed in 4 different positions in a pediatric ventilator in vitro model. Respir Care. 2013 Jul; 58(7):1124-33. PMID: 23107173.
      View in: PubMed
    51. Kim J, Xi J, Si X, Berlinski A, Su WC. Hood nebulization: effects of head direction and breathing mode on particle inhalability and deposition in a 7-month-old infant model. J Aerosol Med Pulm Drug Deliv. 2014 Jun; 27(3):209-18. PMID: 23808762.
      View in: PubMed
    52. Berlinski A. In-vitro nebulized albuterol delivery in a model of spontaneously breathing children with tracheostomy. Respir Care. 2013; [Epub ahead of print].
    53. Berlinski A. Nebulized albuterol delivery in a model of spontaneously breathing children with tracheostomy. Respir Care. 2013 Dec; 58(12):2076-86. PMID: 23674810.
      View in: PubMed
    54. Robbins K, Lowe G, Berlinski A. Determining Supplemental Oxygen requirements for activities of daily living in an adolescent patient. Respir Care 57(10):1746. 2013.
    55. Awad S, Berlinski A. Longitudinal evaluation of compressor-nebulizer performance during intense utilization. 2013; 187:A4112 .
    56. A Berlinski, S Holt, T Thurman, M Heulitt. Albuterol delivery during mechanical ventilation in an ex-vivo porcine model. International Society for Aerosols in Medicine. 2013.
    57. Kim J, Xi J, Si X, Berlinski A, Su W. . Hood nebulization: effects of head direction and breathing mode on particle inhalability and deposition in a 7 month old infant model. J Aerosol Med Pulm Drug Deliv. 2013.
    58. Berlinski A, Chavez A. Albuterol delivery via metered dose inhaler in a spontaneously breathing pediatric tracheostomy model. Pediatr Pulmonol. 2013 Oct; 48(10):1026-34. PMID: 23129547.
      View in: PubMed
    59. Berlinski A, Willis JR. Aerosol delivery by 4 different nebulizers placed in 4 different positions in a pediatric ventilator in-vitro model. Respir Care. 2012; [Epub ahead of print].
    60. Xi J, Berlinski A, Zhou Y, Greenberg B, Ou X. Breathing resistance and ultrafine particle deposition in nasal-laryngeal airways of a newborn, an infant, a child, and an adult. Ann Biomed Eng. 2012 Dec; 40(12):2579-95. PMID: 22660850.
      View in: PubMed
    61. Berlinski A. An ounce of prevention is worth a pound of cure. Respir Care. 2012 Apr; 57(4):657-8. PMID: 22472505.
      View in: PubMed
    62. Willis LD, Berlinski A. Survey of aerosol delivery techniques to spontaneously breathing tracheostomized children. Respir Care. 2012 Aug; 57(8):1234-41. PMID: 22348743.
      View in: PubMed
    63. A Berlinski, J Hayden. Does Occlusion Of The Mask Holes Improve Nebulized Albuterol Delivery?. AM J Respir Crit Care Med. 2012; 185;2012:A3356.
    64. Myers T, Berlinski A, Rubin B, Dhand R. Aerosol Therapy In Spontaneously Breathing & Mechanically Ventilated Patients: Description, Selection & Issues. Clinical Foundations. 2012; 10:7-11.
    65. A Berlinski. Editorial: An Ounce of Prevention is Worth a Pound of Cure. Respir Care. 2012; 57(4):657-658.
    66. J Xi, JW Kim, Y Zhou, A Berlinski. Growth of nasal-laryngeal airways in children and their implications in breathing and inhaled aerosol dynamics. Respir Care 57(10):1776. 2012.
    67. A Berlinski. Aerosol physiology and pitfalls using current delivery systems. Pediatr Pulmonol. 2012; Suppl 35:146-148.
    68. Willis D, Berlinski A. A Survey of Aerosol Delivery Techniques to Spontaneously Breathing Tracheostomized Children. 2012.
    69. A Berlinski, J Hayden. Does Occlusion Of The Mask Holes Improve Nebulized Albuterol Delivery?. Am. J Respir Crit Care Med 185;A3356. 2012.
    70. D Geller, A Berlinski. Pediatric Pulmonology. Aerosol Delivery of Medication. 2011.
    71. A Berlinski, Com G, Melguizo M, Jambhekar S. Effect of Position and Lenght of Nebulizer's Reservoir on Albuterol Characteristics and Solution Output. Am. J Respir Crit Care Med. 2011.
    72. A Berlinski, G Lowe, Heulitt M. Wegener's Granulomatosis Seen in an Adolescent Female with Broncho-Pleural Fistula. Respir Care. 2011.
    73. Xi J, Si X, Kim JW, A Berlinski. Simulation of Airflow and Aerosol Deposition in the Nasal Cavity of a 5-year-old Child. J Aerosol Science. 2011; 42(1):156-173.
    74. Randy Willis, A Berlinski. Albuterol Delivery by Three Different Nebulizers Placed in Four Different Positions In a Heated Wire Ventilator Circuit Utilizing a Pediatric Ventilator In-Vitro Model. Respir Care. 2011.
    75. A Berlinski, Hayden J. Albuterol Delivery Via Nebulizer in a Spontaneously Breathing Pediatric Tracheostomy Model. J Aerosol Med Pulm Drug Deliv. 2011; 57.
    76. A Berlinski, Hayden J. Effect of Concomitant Use of Positive Expiratory Pressure Devices and Nebulizers on Nebulized Albuterol Characteristics. Ped Pulmonology. 2011.
    77. A Berlinski, J Hayden. Effect of Position and Length of Nebulizer's Reservoir on Albuterol Characteristics and Solution Output. AM J Respir Crit Care Med. 2011.
    78. A Berlinski, A Chavez, S Holt, M Heulitt. Albuterol Delivery Via MDI/Spacer In A Spontaneously Breathing Pediatric Tracheostomy Model: Does Bagging Improve Drug Delivery?. Am. J Respir Crit Care Med. 2011; 183.
    79. Berlinski A, Willis JR, Leisenring T. In-vitro comparison of 4 large-volume nebulizers in 8 hours of continuous nebulization. Respir Care. 2010 Dec; 55(12):1671-9. PMID: 21122175.
      View in: PubMed
    80. Berlinski A, Willis JR. Albuterol delivery via intrapulmonary percussive ventilator and jet nebulizer in a pediatric ventilator model. Respir Care. 2010 Dec; 55(12):1699-704. PMID: 21122179.
      View in: PubMed
    81. Berlinski A, Hayden JB. Optimization of a procedure used to measure aerosol characteristics of nebulized solutions using a cooled next generation impactor. J Aerosol Med Pulm Drug Deliv. 2010 Dec; 23(6):397-404. PMID: 20958142.
      View in: PubMed
    82. Chavez A, McCracken A, Berlinski A. Effect of face mask dead volume, respiratory rate, and tidal volume on inhaled albuterol delivery. Pediatr Pulmonol. 2010 Mar; 45(3):224-9. PMID: 20146371.
      View in: PubMed
    83. D Willis, A Berlinski. Aerosol Delivery To Spontaneously Breathing Pediatric Patients With A Tracheostomy. American Journal of Respiratory Critical Care Medicine. 2010.
    84. A Chavez, A Berlinski. Factors affecting albuterol deivery via MDI in a spointaneously breathing pediatric trancheostomy model. Am J Respir Crit Care Med. 2010; A3918.
    85. A Berlinski, JR Willis, T Leisenring. In-vitro Comparison of 4 Large-volume Continuous Nebulizers. Respir Care. 2010; 55(12):1671-1679.
    86. A Berlinski, Willis JR. Albuterol Delivery by Intraulmonary Percussive Ventilator and Jet Nebulizer in a Pediatric Ventilator Model. Respir Care. 2010; 55(12):1699-1704.
    87. Chavez A, McCraken A, A Berlinski. Effect of face bask static dead volume, respiratory rate, and tidal volume on inhaled albuterol delivery. Pediatr Pulmonol. 2010; 45(3):224-229.
    88. R Willis, A Berlinski. Albuterol delivery by INTRAPULMONARY PERCUSSIVE VENTILATION (IPV®) and a continuous jet nebulizer in a heated wire ventilator circuit utilizing a pediatric ventilator in-vitro model. 2009; 53(11):1545.
    89. Chavez A, McCraken A, Berlinski A. Effect of face mask static dead volume, respiratory rate and tidal volume on inhaled albuterol delivery. 2009; 179:A4833.
    90. R Willis, A Berlinski. Solution output of a large nebulizer during continuous nebulization: in-vitro vs. in-vivo study. Am J Respir Crit Care Med. 2009.
    91. B Downs, R Willis, A Berlinski. Accuracy of mixing albuterol solutions for inhalation. 2009; 53(11):1545.
    92. Willis L, Berlinski A. Aerosol delivery and airway clearence therapies in Cystic Fibrosis. 2009; Suppl 31:387-388.
    93. G Jones, A Berlinski. Concomitant use of continuous nebulized bronchodilators and heated high flow nasal canula in acute repsiratory distress in a child significantly decreases work of breathing. Respir Care. 2009.
    94. Berlinski A, Chavez A. Effect of mask dead space and inspiratory flow on albuterol delivery by metered-dose inhaler attached to a holding chamber. 2009; 22, 2:197.
    95. A Berlinski, R Willis. Effect of intermittent and continuous operation on nebulizer characteristic: an in-vitro study. Respir Care. 2009.
    96. Maffey AF, Berlinski A, Schkair JC, Teper AM. [Flexible bronchoscopy in a pediatric pulmonology service]. Arch Argent Pediatr. 2008 Feb; 106(1):19-25. PMID: 18636129.
      View in: PubMed
    97. Berlinski A, Carroll JL. Pediatric Respiratory Medicine. Eosinophilic lung diseases and hypersensitivity pneumonitis. 2008.
    98. Stroud MH, Okhuysen-Cawley R, Jaquiss R, Berlinski A, Fiser RT. Successful use of extracorporeal membrane oxygenation in severe necrotizing pneumonia caused by Staphylococcus aureus. Pediatr Crit Care Med. 2007 May; 8(3):282-7. PMID: 17417120.
      View in: PubMed
    99. R Willis, T Leisenring, Berlinski A. In-Vitro Comparison of 4 Continuous Nebulizers. 2007; 52 (11):1583.
    100. Shah SA, Berlinski AB, Rubin BK. Force-dependent static dead space of face masks used with holding chambers. Respir Care. 2006 Feb; 51(2):140-4. PMID: 16441958.
      View in: PubMed
    101. Berlinski A, Waldrep JC. Nebulized drug admixtures: effect on aerosol characteristics and albuterol output. J Aerosol Med. 2006; 19(4):484-90. PMID: 17196077.
      View in: PubMed
    102. A Berlinski. The challenge of delivering aerosols to infants and children. Business Briefing U.S. Repiratory Care. 2006; 27-29.
    103. Berlinski A, M Ali, M Mazumder. Aerosol Characterization of nebulized dry powder formoterol. 2006; A82.
    104. S Shah, Berlinski A, B Rubin. Variability in holding chamber mask dead space volume and seal. Respir Care. 2006; 51(2):140-144.
    105. S Shah, Berlinski A, B Rubin. Variability in holding chamber mask dead space volume and seal. 2005; A236.
    106. CD Kofman, SM Zaragoza, Berlinski A, AF Maffey, SM Vidaurreta, AJ Colom, AM Teper. Comparison of the Bronchodilator Response to Albuterol Delivered by a Jet and an Ultrasonic Nebulizer in Asthmatic Children. 2004; A150.
    107. Berlinski A, F Navarra, M Ivancic, S Fernandez, S Lubovich, G Szulman, P Meyer, V Rodriguez, C Molise, A Maffey, A Teper. Risk Factors for Protracted Clinical course in Infants hospitalized with Bronchiolitis. 2004; A142.
    108. C Kofman, Berlinski A, S Zaragoza, A Teper. Aerosol therapy for pediatric outpatients. RT J Resp Care Pract. 2004; 17:26-28.
    109. Berlinski A, U Emre. Effect of delivery angle on aerosolized bronchodilator output of jet nebulizer. 2004; 817S.
    110. C Kofman, S Zaragoza, Berlinski A, J Muntadas, S Vidaurreta, A Teper. Aerosol therapy in outpatients from a tertiary care children's hospital. 2003; A388.
    111. Kofman C, Berlinski A. C Macri y A Teper Eds. Aerosolterapia in Enfermedades Respiratorias Pediatricas. 2003.
    112. Maffey A, Berlinski A. C Macri y A Teper Eds. Lavado Bronchoalveolar, in Enfermedades Respiratorias Pediatricas. 2003.
    113. Berlinski A, Navarra F, Ivancic M, Fernandez S, Zaragoza S, Castineiras A, Teper A. Bronchiolitis: inpatient population admitted to a tertiary care children's hospital in Argentina. 2002; A675.
    114. Berlinski A, Waldrep JC. Nebulized drug admixtures: effect on aerosol characteristics and drug output of nebulized albuterol. 2001; A442.
    115. Maffey A, Berlinski A, Guagnini M, Fernandez S, Vidaurreta S, Teper A. Flexible fiberoptic bronchoscopy (FBB) in a pediatric pulmonary section: preliminary experience. 2001.
    116. Berlinski A, Waldrep JC. Is there a need for drug furmulation/delivery device indication? Nebulized beclomethasone: a bench study. 2000; A35.
    117. Sweet SC, Berlinski A, Mendeloff EN, Mallory Jr GB, Huddleston CB. Early graft dysfunction in pediatric lung transplant recipients. 1999; 82.
    118. Berlinski A, Waldrep JC. Bench testing of nebulized intranasal glucocorticoid formulations. 1999; A120.
    119. Oermann CM, Berlinski A, Fan LL, Kozinetz CA. Mechanical Ventilation Due to Acute Respiratory Failure in Cystic Fibrosis: Outcome Analysis and Case-control Study. 1999; 287.
    120. Berlinski A, Waldrep JC. Continuous albuterol nebulization: aerosol characterization. 1998; A639.
    121. Berlinski A, Waldrep JC. Metering performance of different metered-dose inhalers and spacers/holding chambers combinations. 1998.
    122. Berlinski A, Waldrep JC. Effect of aerosol delivery system and formulation on nebulized Budesonide output. 1997; A351.
    123. Berlinski A, JC Waldrep. Effect of aerosol delivery system and formulation on nebulized Budesonide output. J Aerosol Medicine. 1997; 10(4):307-318.
    124. Berlinski A, Teper AM. Metacholine inhalation test: comparison between three protocols varying metacholine dose (standard, weight and heigh adjustment) in pediatric asthmatic population. 1996; A558.
    125. Berlinski A. Effect of time and initial volume on final sodium concentration of nebulized isotonic saline solution. 1995; A745.
    Berlinski's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (161) concept(s)
    _
    Co-Authors Expand Description
    See all (13) people
    _
    Similar People Expand Description
    See all (30) people
    _
    Same Department Expand Description
    Search Department